{"id":12919,"date":"2026-02-18T17:50:16","date_gmt":"2026-02-18T14:50:16","guid":{"rendered":"https:\/\/nesiller.com\/test-list\/"},"modified":"2026-10-03T18:36:55","modified_gmt":"2026-10-03T15:36:55","slug":"test-list","status":"publish","type":"page","link":"https:\/\/nesiller.com\/en\/test-list\/","title":{"rendered":"Test List"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\u00d6zel Nesiller Genetik<\/div>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

Test List<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
Order No.<\/th>Test Name<\/th>Gene\/Region<\/th>Indication<\/th>Analysis Method<\/th>Sample Type<\/th>Sample Tube<\/th>Amount (min)<\/th>Transport Conditions<\/th>TAT (days)<\/th>\n<\/tr>\n<\/thead>\n
1<\/td>13, 18, 21, X and Y Chromosome Rapid FISH<\/td>13, 18, 21, X and Y Chromosome<\/td>\u2022 Chromosomal Disease Suspicion \u2022 Infertility<\/td>FISH Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>3<\/td>\n<\/tr>\n
2<\/td>5HTT (SLC6A4) Mutation Analysis<\/td>SLC6A4 (Short Allele or Deletion)<\/td>\u2022 SSRI Sensitivity and Dose Adjustment<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
3<\/td>ABL1 Gene Mutation Analysis<\/td>ABL1 (Exon 4, 5, 6)<\/td>\u2022 Cancer, \u2022 Response to Drug Treatment<\/td>Sequence Analysis<\/td>Blood (EDTA), Bone Marrow (EDTA), FFPE<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
4<\/td>ACE Gene Mutation Analysis<\/td>ACE<\/td>\u2022 Cardiovascular Risk<\/td>Gel Electrophoresis<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
5<\/td>ACTA2 Gene Mutation Analysis<\/td>ACTA2 (Whole Gene)<\/td>\u2022 Thoracic Aortic Aneurysm Aortic Dissection Type 4<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
6<\/td>ADA Gene Mutation Analysis<\/td>ADA (Whole Gene)<\/td>\u2022 Adenosine Deaminase Deficiency<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
7<\/td>Alpha-1-Antitrypsin Deficiency<\/td>Protease Inhibitor (Pi)<\/td>\u2022 Alpha-1-Antitrypsin Deficiency (AAT)<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
8<\/td>APOE Gene Allele Analysis<\/td>APOE<\/td>\u2022 Cardiovascular Risk<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
9<\/td>ARSA Gene Mutation Analysis<\/td>ARSA (Whole Gene)<\/td>\u2022 Metachromatic Leukodystrophy<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
10<\/td>ASPA Gene Mutation Analysis<\/td>ASPA (Whole Gene)<\/td>\u2022 Canavan Disease<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
11<\/td>ATP7B Gene Sequence Analysis<\/td>ATP7B<\/td>Wilson Disease<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>21<\/td>\n<\/tr>\n
12<\/td>BCR\/ABL Translocation<\/td>BCR-ABL t(9;22)<\/td>\u2022 Cancer<\/td>Real-Time PCR<\/td>Blood (EDTA), Bone Marrow (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
13<\/td>BRAF + NRAS Gene Mutation Analysis<\/td>BRAF (Exon 11, 15) + NRAS (Exon 1, 2, 3)<\/td>\u2022 Cancer, \u2022 Response to Drug Treatment<\/td>Real-Time PCR<\/td>Blood (Streck), FFPE<\/td>EDTA Tube (purple cap)<\/td>10 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
14<\/td>BRAF Gene Mutation Analysis<\/td>BRAF (Exon 11, 15)<\/td>\u2022 Cancer, \u2022 Response to Drug Treatment<\/td>Sequence Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10<\/td>\n<\/tr>\n
15<\/td>BRCA1 - BRCA2 Gene Mutation Analysis<\/td>BRCA1 (Whole Gene), BRCA2 (Whole Gene)<\/td>\u2022 Cancer \u2022 Cancer Predisposition \u2022 Response to Drug Treatment<\/td>NGS<\/td>Blood (EDTA), FFPE<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>45<\/td>\n<\/tr>\n
16<\/td>BRCA1-2 Gene Deletion\/Duplication<\/td>BRCA1 & BRCA 2<\/td>Cancer<\/td>MLPA<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>5 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>30<\/td>\n<\/tr>\n
17<\/td>BTD Gene Sequence Analysis<\/td>BTD<\/td>Biotinidase Deficiency<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>21<\/td>\n<\/tr>\n
18<\/td>CALR (Calreticulin) Gene Mutation Analysis<\/td>CALR<\/td>Essential Thrombocythemia and Primary Myelofibrosis<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
19<\/td>CFTR Gene Mutation Analysis<\/td>CFTR<\/td>\u2022 Cystic Fibrosis<\/td>NGS \/ Fragment Analysis \/ Sequence Analysis \/ MLPA<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>10<\/td>\n<\/tr>\n
20<\/td>CHEK2 Gene Mutation Analysis<\/td>CHEK2 (Exon 9, 10)<\/td>\u2022 Cancer, \u2022 Li-Fraumeni Syndrome Type II, \u2022 Drug Response, \u2022 Anthracyclines<\/td>Sequence Analysis<\/td>Blood (EDTA), FFPE<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
21<\/td>CHRNE Gene Mutation Analysis<\/td>CHRNE (Exon 11, 12)<\/td>\u2022 Congenital Myasthenic Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
22<\/td>CLAUDIN 18.2 Gene Mutation Analysis<\/td>CLAUDIN 18.2 (Whole Gene)<\/td>Cancer<\/td>IHC<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10<\/td>\n<\/tr>\n
23<\/td>CLCN7 Gene Mutation Analysis<\/td>CLCN7 (Whole Gene)<\/td>\u2022 Osteopetrosis<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
24<\/td>Connexin 26 Gene Mutation Analysis<\/td>Connexin 26 (Exon 2)<\/td>\u2022 Congenital Deafness<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
25<\/td>CRLF1 Gene Mutation Analysis<\/td>CRLF1 (Whole Gene)<\/td>\u2022 Cold-Induced Sweating Syndrome Type 1<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
26<\/td>CYP1A2 Mutation Analysis<\/td>CYP1A2 (*1C, *1F)<\/td>\u2022 Drug Treatment Response \u2022 Dose Adjustment<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
27<\/td>CYP2C19 Gene Mutation Analysis<\/td>CYP2C19 (*1, *2, *3, *4, *17)<\/td>\u2022 Drug Treatment Response \u2022 Dose Adjustment<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
28<\/td>CYP3A4 Mutation Analysis<\/td>CYP3A4 (*2)<\/td>\u2022 Drug Treatment Response \u2022 Dose Adjustment<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
29<\/td>DHCR7 Gene Mutation Analysis<\/td>DHCR7 (Whole Gene)<\/td>\u2022 Smith-Lemli-Opitz Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>45<\/td>\n<\/tr>\n
30<\/td>Dystrophin Gene Mutation Analysis<\/td>Dystrophin (79 Exons)<\/td>\u2022 DMD\/BMD<\/td>MLPA<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
31<\/td>DNA Identification (Pre-Freezing)<\/td>STR (Short Tandem Repeat) Regions<\/td>Identity verification before freezing.<\/td>Fragment Analysis<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
32<\/td>DOK7 Gene Mutation Analysis<\/td>DOK7 (Whole Gene)<\/td>\u2022 Pena-Shokeir Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
33<\/td>DPYD Gene Mutation Analysis<\/td>DPYD (IVS14 + 1G>A, DPYD*2A)<\/td>\u2022 DPD Deficiency \u2022 5-Fluorouracil Toxicity<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
34<\/td>EGFR Gene Mutation Analysis<\/td>EGFR (Exon 18, 19, 20, 21)<\/td>\u2022 Cancer, \u2022 Response to Drug Treatment<\/td>Real-Time PCR<\/td>FFPE \/ Blood (Streck)<\/td>EDTA Tube (purple cap)<\/td>10 ML<\/td>2-8\u00b0C, deliver within 24h. No direct ice contact.<\/td>10<\/td>\n<\/tr>\n
35<\/td>ELA2 Gene Mutation Analysis<\/td>ELA2 (Whole Gene)<\/td>\u2022 Neutropenia<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
36<\/td>PGT-A (NGS)<\/td>24 Chromosomes - Numerical and Structural Disorders<\/td>\u2022 Numerical and Structural Anomalies \u2022 Klinefelter, Mosaic Turner, etc. \u2022 Advanced Maternal Age \u2022 Recurrent Pregnancy Loss \u2022 Recurrent IVF Failure<\/td>NGS<\/td>Day 5 (Trophectoderm) Biopsy<\/td>Specialized PBS tubes provided by center<\/td>5-10 cells<\/td>Room temperature<\/td>15<\/td>\n<\/tr>\n
37<\/td>PGT-A + PGT-SR (NGS)<\/td>24 Chromosomes - Translocation, Inversion<\/td>Maternal and\/or Paternal Translocation\/Inversion carrier status<\/td>NGS<\/td>Day 5 (Trophectoderm) Biopsy<\/td>Specialized PBS tubes provided by center<\/td>5-10 cells<\/td>Room temperature<\/td>3 Weeks<\/td>\n<\/tr>\n
38<\/td>EndoPredict<\/td>UBE2C, BIRC5, DHCR7, STC2, AZGP1, IL6ST, RBBP8, MGP, OAZ1, CALM2, RPL37A, HBB<\/td>Breast Cancer<\/td>Real-Time PCR<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>2-3 weeks<\/td>\n<\/tr>\n
39<\/td>ESR1 Gene Mutation Analysis<\/td>ESR1 (Whole Gene)<\/td>Cancer<\/td>Digital PCR<\/td>FFPE \/ Blood<\/td>EDTA Tube (purple cap)<\/td>2-3 mL<\/td>2-8\u00b0C, deliver within 24h. No direct ice contact.<\/td>10<\/td>\n<\/tr>\n
40<\/td>F9 Gene Mutation Analysis<\/td>F9 (Whole Gene)<\/td>\u2022 Hemophilia B<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
41<\/td>Factor II Gene Mutation Analysis<\/td>Factor II (Prothrombin)<\/td>\u2022 Cardiovascular Risk - FII Deficiency<\/td>Real-Time PCR<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
42<\/td>Factor V Leiden Mutation Analysis<\/td>Factor V<\/td>\u2022 Cardiovascular Risk - FVL Thrombophilia<\/td>Real-Time PCR<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
43<\/td>Factor V Mutation Analysis<\/td>Factor V (H1299R)<\/td>\u2022 Cardiovascular Risk - FVL Thrombophilia<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
44<\/td>Factor XIII Mutation Analysis<\/td>Factor XIII (V34L)<\/td>\u2022 Cardiovascular Risk - FXIII Deficiency<\/td>Real-Time PCR<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
45<\/td>FBN1 Gene Mutation Analysis<\/td>FBN1 (Whole Gene)<\/td>\u2022 Marfan Syndrome<\/td>NGS<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
46<\/td>FGB Gene Mutation Analysis<\/td>FGB (Beta-Fibrinogen) (455G>A)<\/td>\u2022 Cardiovascular Risk<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
47<\/td>FGFR3 Gene Mutation Analysis<\/td>FGFR3 (Exon 9, 10, 13, 15)<\/td>\u2022 Achondroplasia<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>15<\/td>\n<\/tr>\n
48<\/td>FGFR3 Gene Mutation Analysis<\/td>FGFR3 (Exon 10)<\/td>\u2022 Hypochondroplasia<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>10<\/td>\n<\/tr>\n
49<\/td>FGFR3 Gene Mutation Analysis<\/td>FGFR3 (Exon 9, 10, 13, 15)<\/td>\u2022 Hypochondroplasia<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>15<\/td>\n<\/tr>\n
50<\/td>FGFR3 Gene Mutation Analysis<\/td>FGFR3 (Exon 10, 15)<\/td>\u2022 Thanatophoric Dysplasia<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>10<\/td>\n<\/tr>\n
51<\/td>FISH Analysis - IGH\/MYC Translocation and Fusion<\/td>MYC\/IGH 8q24.21\/14q32.33 t(8;14)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
52<\/td>FISH Analysis - PML\/RARA Translocation and Fusion<\/td>PML\/RARA 15q22\/17q21.1 t(15;17)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
53<\/td>FISH Analysis - 13q14.3 Deletion<\/td>D13S319 (13q14.3)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin)<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
54<\/td>FISH Analysis - 1p\/19q Deletions<\/td>1p36 & 19q13<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
55<\/td>FISH Analysis - 20\/20q Deletion<\/td>20q13.2<\/td>\u2022 AML, \u2022 MDS, \u2022 Polycythemia Vera (PV) \u2022 Prognosis and Treatment Response<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin)<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
56<\/td>FISH Analysis - 7\/7q Deletion or Chromosome 7 Aneuploidy<\/td>7\/7q- (7q31)<\/td>\u2022 Cancer, \u2022 Myelodysplastic Syndromes (MDS)<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
57<\/td>FISH Analysis - API2\/MALT1 Translocation and Fusion<\/td>API2\/MALT1 11q21\/18q21 t(11;18)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
58<\/td>FISH Analysis - ATM Translocation<\/td>ATM (11q22.3)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
59<\/td>FISH Analysis - AURKA<\/td>AURKA (20q13)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
60<\/td>FISH Analysis - BCR\/ABL Translocation and Fusion<\/td>BCR\/ABL 22q11.22\/9q34.11 t(9;22)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
61<\/td>FISH Analysis - C-MET Amplification and Chromosome 7 Aneuploidy<\/td>C-MET (7q31.2)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
62<\/td>FISH Analysis - C-MYC Amplification<\/td>C-MYC (8q24)<\/td>\u2022 Cancer, \u2022 Barrett's Esophagus<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
63<\/td>FISH Analysis - CBFB\/MYH11 Translocation and Fusion<\/td>CBFB (16q22) MYH11 (16p13.1) t(16;16)<\/td>\u2022 Cancer, \u2022 Eosinophilic Syndromes<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
64<\/td>FISH Analysis - CCND1\/IGH Translocation and Fusion<\/td>CCND1\/IGH 11q13\/14q32 t(11;14)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
65<\/td>FISH Analysis - E2A (TCF3) Translocation<\/td>E2A (TCF3) (19p13.3)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
66<\/td>FISH Analysis - EGFR Amplification and Chromosome 7 Aneuploidy<\/td>EGFR (7p12)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
67<\/td>FISH Analysis - EGR1 Deletion or Chromosome 5 Aneuploidy<\/td>EGR1 (5q31)<\/td>\u2022 Cancer, \u2022 Myelodysplastic Syndromes (MDS)<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
68<\/td>FISH Analysis - EML4\/ALK<\/td>EML4\/ALK<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
69<\/td>FISH Analysis - ETO\/AML1 Translocation and Fusion<\/td>ETO\/AML1 8q21.3\/21q22.12 t(8;21)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
70<\/td>FISH Analysis - EWSR1 Translocation<\/td>EWSR1 (22q12)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
71<\/td>FISH Analysis - FIP1L1\/PDGFRA Translocation<\/td>FIP1L1\/PDGFRA (4q12)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
72<\/td>FISH Analysis - HER2\/NEU Amplification and Deletion<\/td>HER2\/NEU (17q11.2-12) (C-ERBB2)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
73<\/td>FISH Analysis - IGH Translocation<\/td>IGH (14q32)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
74<\/td>FISH Analysis - IGH\/BCL2 Translocation and Fusion<\/td>IGH\/BCL2 14q32\/18q21 t(14;18)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
75<\/td>FISH Analysis - IGH\/FGFR3 Translocation and Fusion<\/td>IGH\/FGFR3 4p16.3\/14q32.33 t(4;14)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
76<\/td>FISH Analysis - IGH\/MAF Translocation and Fusion<\/td>IGH\/MAF 14q32\/16q23 t(14;16)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
77<\/td>FISH Analysis - Chromosome 12 Aneuploidy<\/td>Chromosome 12<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
78<\/td>FISH Analysis - Chromosome 8 Aneuploidy<\/td>Chromosome 8<\/td>\u2022 Cancer, \u2022 Myelodysplastic Syndrome (MDS)<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin)<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
79<\/td>FISH Analysis - LAMP1 Translocation<\/td>LAMP1 (13q34)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin)<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
80<\/td>FISH Analysis - MALT1 Translocation and Chromosome 18 Aneuploidy<\/td>MALT1 (18q21)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
81<\/td>FISH Analysis - MLL Translocation<\/td>MLL (11q23)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
82<\/td>FISH Analysis - N-MYC Amplification and Chromosome 2 Aneuploidy<\/td>N-MYC (2p24.3)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
83<\/td>FISH Analysis - P53 Deletion<\/td>P53 (17p13.1)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
84<\/td>FISH Analysis - PD-L1&2 (CD274) Amplification and Deletion<\/td>PD-L1&2 (9p24.1)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
85<\/td>FISH Analysis - RB1 Deletion<\/td>RB1 (13q14)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
86<\/td>FISH Analysis - ROS1 Translocation<\/td>ROS1 (6q22.1)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
87<\/td>FISH Analysis - TEL\/AML1 Translocation<\/td>TEL\/AML1 (12q13.2 \/ 21q22.12)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
88<\/td>FISH Analysis - TOP2A Amplification and Deletion<\/td>TOP2A (17q21.2)<\/td>\u2022 Cancer, \u2022 Drug Response, \u2022 Anthracyclines<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
89<\/td>FISH Analysis \u2013 ALK Translocation and Fusion<\/td>ALK (2p23)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
90<\/td>FISH Analysis \u2013 IGF1R Amplification and Deletion<\/td>IGF1R (15q26)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>7<\/td>\n<\/tr>\n
91<\/td>FISH Analysis \u2013 RARA Translocation<\/td>RARA (17q21)<\/td>\u2022 Cancer<\/td>FISH Analysis<\/td>Bone Marrow (Heparin), Blood (Heparin), FFPE<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
92<\/td>FLT3 Gene Mutation Analysis<\/td>FLT3 ITD and D835<\/td>\u2022 Cancer<\/td>Sequence Analysis<\/td>Blood (EDTA), Bone Marrow (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
93<\/td>FMF Mutation Analysis<\/td>MEFV<\/td>\u2022 Familial Mediterranean Fever<\/td>Sequence Analysis \/ NGS<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>10<\/td>\n<\/tr>\n
94<\/td>FMR1 Gene CGG Repeat Analysis<\/td>FMR1<\/td>\u2022 Fragile X Syndrome<\/td>Fragment Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
95<\/td>Focus Lung Fusion<\/td>ALK, BRAF, EGFR, ERBB2, FGFR1, FGFR2, FGFR3, KRAS, MET, NRG1, NTRK1, NTRK2, NTRK3, NUTM1, PIK3CA, RET, ROS1<\/td>Cancer<\/td>NGS<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10-14 Days<\/td>\n<\/tr>\n
96<\/td>Focus Lung and Colon<\/td>AKT1, ALK, BRAF, CTNNB1, EGFR, ERBB2, ERBB3, ESR1, FOXL2, GNA11, GNAQ, IDH1, IDH2, KIT, KRAS, MET, NRAS, PDGFRA, PIK3CA, RAF1, RET, TP53<\/td>Cancer<\/td>NGS<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10-14 Days<\/td>\n<\/tr>\n
97<\/td>FOCUS CGP<\/td>ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, AMER1 (FAM123B or WTX), APC, AR, ARAF, ARFRP1, ARID1A, ASXL1, ATM, ATR, ATRX, AURKA, AURKB, AXIN1, AXL, B2M, BAP1, BARD1, BCL2, BCL2L1, BCL2L2, BCL6, BCOR, BCORL1, BRAF, BRCA1, BRCA2, BRD4, BRIP1, BTG1, BTG2, BTK, CALR, CARD11, CASP8, CBFB, CBL, CCND1, CCND2, CCND3, CCNE1, CD22, CD274 (PD-L1), CD70, CD79A, CD79B, CDC73, CDH1, CDK12, CDK4, CDK6, CDK8, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CDKN2C, CEBPA, CHEK1, CHEK2, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DDR2, DICER1, DIS3, DNMT3A, DOT1L, EED, EGFR, EMSY (C11orf30), EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ERRFI1, ESR1, ETV6, EZH2, FANCA, FANCC, FANCG, FANCL, FAS, FBXW7, FGF10, FGF12, FGF14, FGF19, FGF23, FGF3, FGF4, FGF6, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, FOXL2, FUBP1, GABRA6, GATA3, GATA4, GATA6, GID4 (C17orf39), GNA11, GNA13, GNAQ, GNAS, GRM3, GSK3B, H3-3A (H3F3A), HDAC1, HGF, HNF1A, HRAS, HSD3B1, ID3, IDH1, IDH2, IGF1R, IKBKE, IKZF1, IKZF2, IKZF3, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, JUN, KDM5A, KDM5C, KDM6A, KDR, KEAP1, KEL, KIT, KLHL6, KMT2A (MLL), KMT2D (MLL2), KRAS, LTK, LYN, MAF, MAP2K1 (MEK1), MAP2K2 (MEK2), MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MDM4, MED12, MEF2B, MEN1, MERTK, MET, MITF, MKNK1, MLH1, MPL, MRE11 (MRE11A), MSH2, MSH3, MSH6, MST1R, MTAP, MTOR, MUTYH, MYC, MYCL (MYCL1), MYCN, NBN, MYD88, NF1, NF2, NFE2L2, NFKBIA, NKX2-1, NOTCH1, NOTCH2, NOTCH3, NOTCH4, NPM1, NRAS, NSD2 (WHSC1 or MMSET), NSD3 (WHSC1L1), NT5C2, NTRK1, NTRK2, NTRK3, P2RY8, PALB2, PARP1, PARP2, PARP3, PAX5, PBRM1, PDCD1 (PD-1), PDCD1LG2 (PD-L2), PDGFRA, PDGFRB, PDK1, PIK3C2B, PIK3CA, PIK3CB, PIK3R1, PIM1, PLCG2, PMS2, POLD1, POLE, PPARG, PPP2R1A, PPP2R2A, PRDM1, PRKAR1A, PRKCI, PRKN (PARK2), PTCH1, PTEN, PTPN11, PTPRO, QKI, RAC1, RAD21, RAD51, RAD51B, RAD51C, RAD51D, RAD52, RAD54L, RAF1, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RUNX1, SDHA, SDHB, SDHC, SDHD, SETD2, SF3B1, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SMO, SNCAIP, SOCS1, SOX2, SOX9, SPEN, SPOP, SRC, SRSF2, STAG2, STAT3, STK11, SUFU, SYK, TBX3, TEK, TENT5C (FAM46C), TET2, TGFBR2, TIPARP, TNFAIP3, TNFRSF14, TP53, TP53BP1, TSC1, TSC2, TYRO3, U2AF1, VEGFA, VHL, WT1, XPO1, XRCC2, ZEB2, ZNF217, ZNF703, ZRSF2.<\/td>Cancer<\/td>NGS \/ Hybrid Capture<\/td>FFPE \/ FNA \/ Cell Block<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>2-3 Weeks<\/td>\n<\/tr>\n
98<\/td>Focus Lymphoma<\/td>ATM, BIRC3, BRAF, DDX3X, DNMT3A, ID3, IDH2, KLF2, MYC, MYD88, NFKBIE, NOTCH1, NOTCH2, RHOA, SF3B1, STAT3, TCF3, TET2, TP53<\/td>Cancer<\/td>NGS<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10-14 Days<\/td>\n<\/tr>\n
99<\/td>Focus Myeloid<\/td>ASXL1, CALR, CBL, CEBPA, CSF3R, DNMT3A, EZH2, FLT3, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NPM1, NRAS, RUNX1, SETBP1, SF3B1, SH2B3, SRSF2, TET2, TP53, U2AF1, ZRSR2<\/td>Cancer<\/td>NGS<\/td>Bone Marrow \/ Blood<\/td>EDTA Tube (purple cap)<\/td>2-3 mL<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10-14 Days<\/td>\n<\/tr>\n
100<\/td>Focus Sarcoma Fusion<\/td>ALK, BCOR, BRAF, CAMTA1, CCNB3, CIC, CSF1, CTNNB1, EGFR, EPC1, ERG, ESR1, ETV1, ETV4, ETV5, ETV6, EWSR1, FGFR1, FGFR2, FGFR3, FOS, FOSB, FOXO1, FUS, GLI1, HMGA2, JAZF1, MBTD1, MDM2, MEAF6, MET, MGEA5, MKL2, MYOD1, NCOA1, NCOA2, NCOA3, NR4A3, NTRK1, NTRK2, NTRK3, NUTM1, PAX3, PDGFB, PDGFRA, PHF1, PLAG1, PRKCA, PRKCB, PRKCD, RAF1, RET, ROS1, SS18, STAT6, TAF15, TCF12, TFE3, TFG, USP6, VGLL2, YAP1, YWHAE<\/td>Cancer<\/td>NGS<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10-14 Days<\/td>\n<\/tr>\n
101<\/td>FOCUS SOLID + MSI<\/td>AKT1, ALK, APC, AR, ATRX, BRAF, CDK4, CDK6, CDKN2A, CTNNB1, DDR2, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FBXW7, FGFR1, FGFR2, FGFR3, FOXL2, GNA11, GNAQ, GNAS, H3F3A, HIST1H3B, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MAP2K1, MAP2K2, MET, MTOR, MYC, NOTCH1, NOTCH2, NOTCH3, NOTCH4, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA, POLD1, POLE, PTEN, RAF1, RB1, RET, RICTOR, ROS1, SMAD4, SMO, TERT, TP53, VHL<\/td>Cancer<\/td>NGS<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10-14 Days<\/td>\n<\/tr>\n
102<\/td>FSHB Gene Mutation Analysis<\/td>FSHB (211G>T)<\/td>\u2022 Infertility<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
103<\/td>G6PC Gene Mutation Analysis<\/td>G6PC (Whole Gene)<\/td>\u2022 GSD Type 1A (Von Gierke)<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
104<\/td>G6PD Gene Mutation Analysis<\/td>G6PD (Whole Gene)<\/td>\u2022 G6PD Deficiency<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
105<\/td>GALK1 Gene Mutation Analysis<\/td>GALK1 (Whole Gene)<\/td>\u2022 Galactokinase Deficiency<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
106<\/td>GALNS Gene Mutation Analysis<\/td>GALNS (Whole Gene)<\/td>\u2022 Mucopolysaccharidosis Type IVA<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
107<\/td>GALT Gene Mutation Analysis<\/td>GALT (Whole Gene)<\/td>\u2022 Galactosemia<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
108<\/td>GATA3 Gene Mutation Analysis<\/td>GATA3 (Whole Gene)<\/td>\u2022 Hypoparathyroidism-Deafness-Renal Dysplasia<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
109<\/td>GATA3 Gene Mutation Analysis<\/td>GATA3 (Whole Gene)<\/td>\u2022 HDR Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
110<\/td>GJB1 Gene Mutation Analysis<\/td>GJB1 (Whole Gene)<\/td>\u2022 Congenital Deafness<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
111<\/td>GLA Gene Mutation Analysis<\/td>GLA (Whole Gene)<\/td>\u2022 Fabry Disease<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
112<\/td>GSTM1 Mutation Analysis<\/td>GSTM1<\/td>\u2022 Drug Toxicity \u2022 Cancer Risk Analysis<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
113<\/td>HAE Gene Mutation Analysis<\/td>HAE<\/td>\u2022 Factor XII<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>10<\/td>\n<\/tr>\n
114<\/td>HBA1 & HBA2 Gene Mutation Analysis<\/td>HBA1, HBA2<\/td>\u2022 Alpha Thalassemia<\/td>\u2022 Sequence Analysis \u2022 MLPA<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
115<\/td>HBB Gene Mutation Analysis<\/td>HBB (Whole Gene)<\/td>\u2022 Beta Thalassemia<\/td>\u2022 Sequence Analysis \u2022 MLPA<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>15<\/td>\n<\/tr>\n
116<\/td>HFE Gene Mutation Analysis<\/td>HFE (H63D and C282Y)<\/td>\u2022 Hemochromatosis<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
117<\/td>HLA + Single Gene Disease (PGT-M)<\/td>HLA + Single Gene Disease<\/td><\/td>Sequence Analysis<\/td>Day 5 TE Biopsy Family: Blood (EDTA)<\/td>Specialized PBS tubes provided by center<\/td>5-10 cells<\/td>Room temperature<\/td>8 Weeks<\/td>\n<\/tr>\n
118<\/td>HLA Gene Mutation Analysis<\/td>HLA (DQ2, DQ8)<\/td>\u2022 Celiac Disease \u2013 Gluten Intolerance<\/td>Real-Time PCR<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
119<\/td>HLA-B5 Gene Mutation Analysis<\/td>HLA-B5<\/td>Behcet's Disease<\/td>Real-Time PCR<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>10<\/td>\n<\/tr>\n
120<\/td>HLA-DQ2, HLA-DQ8<\/td>HLA-DQ2, HLA-DQ8<\/td>Celiac Disease<\/td>Real-Time PCR<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>10<\/td>\n<\/tr>\n
121<\/td>HLAB27 Gene Mutation Analysis<\/td>HLAB27<\/td>\u2022 Autoimmune Diseases<\/td>Real-Time PCR<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
122<\/td>HPA1 Gene Allele Analysis<\/td>HPA1<\/td>\u2022 Cardiovascular Risk<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
123<\/td>HRAS Gene Mutation Analysis<\/td>HRAS (Exon 1, 2)<\/td>\u2022 Cancer<\/td>Sequence Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10<\/td>\n<\/tr>\n
124<\/td>IDH1 Gene Mutation Analysis<\/td>IDH1 (Exon 4)<\/td>\u2022 Cancer<\/td>Sequence Analysis<\/td>Blood (EDTA), Bone Marrow (EDTA), FFPE<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
125<\/td>IDH2 Gene Mutation Analysis<\/td>IDH2 (Exon 4)<\/td>\u2022 Cancer<\/td>Sequence Analysis<\/td>Blood (EDTA), Bone Marrow (EDTA), FFPE<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
127<\/td>IDS Gene Mutation Analysis<\/td>IDS (Whole Gene)<\/td>\u2022 Mucopolysaccharidosis Type II<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
128<\/td>IDUA Gene Mutation Analysis<\/td>IDUA (Whole Gene)<\/td>\u2022 Hurler Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA Tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
129<\/td>Drug Sensitivity Panel - Extended<\/td>CYP2D6, CYP2C9, CYP2C19, NAT2, CYP1A2<\/td>\u2022 Drug Treatment Response \u2022 Dose Adjustment<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
130<\/td>Drug Sensitivity Panel - Neuropsychiatry<\/td>CYP2D6, CYP2C9, CYP2C19, CYP1A2, CYP3A4<\/td>\u2022 Drug Treatment Response \u2022 Dose Adjustment<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
131<\/td>Drug Sensitivity Panel - Standard<\/td>CYP2D6, CYP2C9, CYP2C19<\/td>\u2022 Drug Treatment Response \u2022 Dose Adjustment<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
132<\/td>Drug Sensitivity - CYP2D6 Mutation Analysis<\/td>CYP2D6 (*1, *2, *3, *4, *6, *7, *8, *9, *10, *11, *12, *14, *17, *29, *39, *41)<\/td>\u2022 Drug Treatment Response \u2022 Dose Adjustment<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
133<\/td>Drug Sensitivity - VKORC1 Gene Mutation Analysis<\/td>VKORC1 (-1639C>A)<\/td>\u2022 Drug Treatment Response \u2022 Dose Adjustment<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
134<\/td>Drug Sensitivity - Warfarin Dose Panel<\/td>CYP2C9, VKORC1<\/td>\u2022 Drug Treatment Response \u2022 Dose Adjustment<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
135<\/td>JAK2 Gene Mutation Analysis<\/td>JAK2 (V617F)<\/td>\u2022 Cancer, \u2022 Essential Thrombocythemia (ET), \u2022 HES, \u2022 MDS, \u2022 Polycythemia Vera (PV), \u2022 Drug Response, \u2022 Relapse Monitoring<\/td>Sequence Analysis<\/td>Blood (EDTA), Bone Marrow (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
136<\/td>JAK2 Gene Mutation Analysis<\/td>JAK2 (Exon 12)<\/td>\u2022 Cancer, \u2022 ET, \u2022 HES, \u2022 MDS, \u2022 PV, \u2022 Drug Response, \u2022 Relapse Monitoring<\/td>Sequence Analysis<\/td>Blood (EDTA), Bone Marrow (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
137<\/td>Comprehensive Obesity and MODY Panel<\/td>MODY (81 Genes; 68 Obesity, 13 MODY)<\/td>\u2022Obesity \u2022 Diabetes<\/td>NGS<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>40<\/td>\n<\/tr>\n
138<\/td>Cardiovascular Risk Panel (12 Mutations)<\/td>FGB, HPA1, ACE, APOE, F13, F2, F5 Leiden, MTHFR etc.<\/td>\u2022 Cardiovascular Risk<\/td>Sequence Analysis + Real-Time PCR<\/td>EDTA Blood<\/td>EDTA Tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
139<\/td>Post-Bone Marrow (BM) Transplantation Monitoring<\/td><\/td>\u2022 Post-Transplant Success<\/td>Molecular<\/td>Blood (EDTA) \/ Bone Marrow (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>30<\/td>\n<\/tr>\n
140<\/td>KIT Gene Mutation Analysis<\/td>KIT (Exon 9, 11, 13, 17)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>Sequence Analysis<\/td>Blood (EDTA), Bone Marrow (EDTA), FFPE<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
141<\/td>Chimerism Analysis - by FISH<\/td>Sex Chromosomes<\/td>\u2022 Post-Transplant Success<\/td>FISH Analysis<\/td>Blood (Heparin) \/ Bone Marrow (Heparin)<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>46145<\/td>\n<\/tr>\n
142<\/td>Chimerism Analysis - by PCR (Recipient - Donor)<\/td>STR Regions<\/td>\u2022 Post-BM Transplant Success<\/td>Fragment Analysis<\/td>Blood (EDTA)<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
143<\/td>KRAS + NRAS Gene Mutation Analysis<\/td>KRAS + NRAS (Codon 12, 13, 59, 61, 117, 146)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>Real-Time PCR<\/td>Blood (Streck), FFPE<\/td>EDTA Tube (purple cap)<\/td>10 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
144<\/td>KRAS Gene Mutation Analysis<\/td>KRAS (Whole Gene)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>Sequence Analysis<\/td>Blood (EDTA), FFPE<\/td>EDTA Tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>21<\/td>\n<\/tr>\n
145<\/td>KRAS Gene Mutation Analysis<\/td>KRAS (Codon 12, 13, 59, 61, 117, 146)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>Real-Time PCR<\/td>Blood (Streck), FFPE<\/td>EDTA Tube (purple cap)<\/td>10 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
146<\/td>Chromosome Analysis - Abortus<\/td>24 Chromosomes<\/td>\u2022 Chromosomal Disease Suspicion \u2022 Multiple Congenital Anomaly \u2022 Recurrent Pregnancy Loss<\/td>Cell Culture<\/td>Abortus Material<\/td>Suitable sample tube<\/td>30-50\u03bcG<\/td>Shipped via cold chain.<\/td>21<\/td>\n<\/tr>\n
147<\/td>Chromosome Analysis - Amniotic Fluid<\/td>24 Chromosomes<\/td>\u2022 Chromosomal Disease Suspicion \u2022 Pathological USG \u2022 Maternal Age \u2022 Abnormal Triple Test<\/td>Cell Culture<\/td>Amniotic Fluid<\/td>Sterile tube<\/td>15-20ML<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
148<\/td>Chromosome Analysis - Skin Tissue<\/td>24 Chromosomes<\/td>\u2022 Chromosomal Disease Suspicion \u2022 Multiple Congenital Anomaly \u2022 Mental Retardation \u2022 Recurrent Pregnancy Loss \u2022 Infertility<\/td>Cell Culture<\/td>Skin Tissue<\/td>Suitable sample tube<\/td>30-50\u03bcG<\/td>Room temperature<\/td>21<\/td>\n<\/tr>\n
149<\/td>Chromosome Analysis - CVS<\/td>24 Chromosomes<\/td>\u2022 Chromosomal Disease Suspicion \u2022 Pathological USG \u2022 Maternal Age \u2022 Abnormal Triple Test<\/td>Cell Culture<\/td>Chorionic Villus<\/td>Deliver in plungerless syringe in RPMI<\/td>2-3 Pcs Villus (2-3MG)<\/td>Room temperature<\/td>21<\/td>\n<\/tr>\n
150<\/td>Chromosome Analysis - Blood<\/td>24 Chromosomes<\/td>\u2022 Chromosomal Disease Suspicion \u2022 Multiple Congenital Anomaly \u2022 Mental Retardation \u2022 Recurrent Pregnancy Loss \u2022 Infertility<\/td>Cell Culture<\/td>Peripheral Blood (Heparinized) \/ Bone Marrow<\/td>Heparinized Blood (Green Cap)<\/td>2-3 ML<\/td>Should be delivered within 24 hours at 15-25 \u00b0C.<\/td>15<\/td>\n<\/tr>\n
151<\/td>Chromosome Analysis - Cord Blood<\/td>24 Chromosomes<\/td>\u2022 Chromosomal Disease Suspicion \u2022 Pathological USG \u2022 Maternal Age \u2022 Abnormal Triple Test<\/td>Cell Culture<\/td>Cord Blood (Heparinized)<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
152<\/td>Chromosome Analysis + Rapid FISH - Amniotic Fluid<\/td>24 Chromosomes<\/td>\u2022 Chromosomal Disease Suspicion \u2022 Pathological USG \u2022 Maternal Age \u2022 Abnormal Triple Test<\/td>Cell Culture<\/td>Amniotic Fluid<\/td>Sterile tube<\/td>15-20ML<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>2 + 21<\/td>\n<\/tr>\n
153<\/td>Chromosome Analysis + Rapid FISH - CVS<\/td>24 Chromosomes<\/td>\u2022 Chromosomal Disease Suspicion \u2022 Pathological USG \u2022 Maternal Age \u2022 Abnormal Triple Test<\/td>Cell Culture<\/td>Chorionic Villus<\/td>Suitable sample tube<\/td>2-3MG<\/td>Room temperature<\/td>2 + 21<\/td>\n<\/tr>\n
154<\/td>Maternal Contamination Test<\/td>STR Regions<\/td>\u2022 Contamination Elimination<\/td>Fragment Analysis<\/td>EDTA Blood + Abortus\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>15<\/td>\n<\/tr>\n
155<\/td>MECP2 Gene Mutation Analysis<\/td>MECP2 (Whole Gene)<\/td>\u2022 Rett Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
156<\/td>MEK1 Gene Mutation Analysis<\/td>MEK1 (Exon 2,3)<\/td>\u2022 Cardiofaciocutaneous Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>15<\/td>\n<\/tr>\n
157<\/td>MEK2 Gene Mutation Analysis<\/td>MEK2 (Exon 1, 2, 3)<\/td>\u2022 Cardiofaciocutaneous Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>15<\/td>\n<\/tr>\n
158<\/td>Microdeletion FISH - Cri-du-chat<\/td>5p15.2<\/td>\u2022 Cri-du-chat Syndrome<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C.<\/td>7<\/td>\n<\/tr>\n
159<\/td>Microdeletion FISH - Prader-Willi\/Angelman<\/td>SNRPN (15q11.2)<\/td>\u2022 Prader-Willi\/Angelman Syndrome<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
160<\/td>Microdeletion FISH - Smith-Magenis<\/td>RAI1 (17p11.2)<\/td>\u2022 Smith-Magenis Syndrome<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
161<\/td>Microdeletion FISH - Sotos<\/td>NSD1 (5q35)<\/td>\u2022 Sotos Syndrome<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
162<\/td>Microdeletion FISH - Wolf-Hirschhorn<\/td>WHSC (4p16.3)<\/td>\u2022 Wolf-Hirschhorn Syndrome<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
163<\/td>Microdeletion FISH - X Inactivation<\/td>XIST (Xq13.2)<\/td>\u2022 X Inactivation<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
164<\/td>Microdeletion FISH - Alagille<\/td>JAG1 (20p12.2)<\/td>\u2022 Alagille Syndrome<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
165<\/td>Microdeletion FISH - DiGeorge\/VCFS<\/td>TUPLE1 (22q11.2)<\/td>\u2022 DiGeorge\/VCFS Syndrome<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
166<\/td>Microdeletion FISH - Diaphragmatic Hernia<\/td>IGF1R (15q26)<\/td>\u2022 Congenital Diaphragmatic Hernia<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
167<\/td>Microdeletion FISH - Kallmann<\/td>KAL1 (Xp22.3)<\/td>\u2022 Kallmann Syndrome<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
168<\/td>Microdeletion FISH - Neurofibromatosis<\/td>NF1 (17q11.2)<\/td>\u2022 Neurofibromatosis Type 1<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
169<\/td>Microdeletion FISH - Williams-Beuren<\/td>ELN (7q11.23)<\/td>\u2022 Williams-Beuren Syndrome<\/td>FISH Analysis<\/td>Heparinized Blood\/AF\/CVS<\/td>Heparinized Blood (Green Cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
170<\/td>Microsatellite Instability (MSI)<\/td>DNA STR Regions<\/td>\u2022 HNPCC (Lynch Syndrome) Screening<\/td>Fragment Analysis<\/td>Blood (EDTA), FFPE<\/td>EDTA tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
171<\/td>Molecular Karyotyping<\/td>24 Chromosomes<\/td>Infertility, Recurrent Loss, Multiple Congenital Anomaly<\/td>aCGH<\/td>EDTA Blood \/AF\/CVS\/Abortus<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>15<\/td>\n<\/tr>\n
172<\/td>MPL Gene Mutation Analysis<\/td>MPL (W515L\/K and S505N)<\/td>\u2022 Cancer, \u2022 Essential Thrombocythemia (ET)<\/td>Sequence Analysis<\/td>Blood (EDTA), Bone Marrow (EDTA)<\/td>EDTA tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
173<\/td>MPZ Gene Mutation Analysis<\/td>MPZ (Whole Gene)<\/td>\u2022 Charcot-Marie-Tooth Disease<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
174<\/td>MTHFR Gene Mutation Analysis<\/td>MTHFR (C677T)<\/td>\u2022 Cardiovascular Risk<\/td>Real-Time PCR<\/td>EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
175<\/td>MTHFR Gene Mutation Analysis<\/td>MTHFR (A1298C)<\/td>\u2022 Cardiovascular Risk<\/td>Real-Time PCR<\/td>EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
176<\/td>MTND Gene Mutation Analysis<\/td>MTND (A52T, R340H, M64V)<\/td>\u2022 Leber Hereditary Optic Neuropathy (LHON)<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
177<\/td>NEU1 Gene Mutation Analysis<\/td>NEU1 (Whole Gene)<\/td>\u2022 Sialidase (Neuraminidase)<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
178<\/td>NGS FOCUS 77L<\/td>77 Cancer Related Genes<\/td>Cancer<\/td>NGS<\/td>ctDNA<\/td>Streck tube \/ EDTA Plasma<\/td>10 ML<\/td>Room temperature<\/td>2-3 Weeks<\/td>\n<\/tr>\n
179<\/td>NGS FOCUS Hereditary<\/td>Cancer Predisposition Genes<\/td>Cancer Predisposition<\/td>NGS<\/td>Blood<\/td>EDTA tube (purple cap)<\/td>2-3 mL<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>4 Weeks<\/td>\n<\/tr>\n
180<\/td>NOTCH3 Gene Mutation Analysis<\/td>NOTCH3 (Exon 3,4)<\/td>\u2022 CADASIL<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
181<\/td>NOTCH3 Gene Mutation Analysis<\/td>NOTCH3 (Exon 3,4,11,18,19)<\/td>\u2022 CADASIL<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>30<\/td>\n<\/tr>\n
182<\/td>Neurofibromatosis Type 1<\/td>NF1 Deletion \/ Duplication<\/td>Suspected NF1 or family history<\/td>MLPA<\/td>Blood (EDTA)<\/td>EDTA tube (purple cap)<\/td>5 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>30<\/td>\n<\/tr>\n
183<\/td>Neurofibromatosis Type 1<\/td>NF1 Targeted Gene Analysis<\/td>Suspected NF1 or family history<\/td>NGS<\/td>Blood (EDTA)<\/td>EDTA tube (purple cap)<\/td>5 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>30<\/td>\n<\/tr>\n
184<\/td>Neurofibromatosis Type 2<\/td>NF2 Deletion \/ Duplication<\/td>Suspected NF2 diagnosis and differentiation<\/td>MLPA<\/td>Blood (EDTA)<\/td>EDTA tube (purple cap)<\/td>5 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>30<\/td>\n<\/tr>\n
185<\/td>Neurofibromatosis Type 2<\/td>NF2 Targeted Gene Analysis<\/td>Suspected NF2 diagnosis and differentiation<\/td>NGS<\/td>Blood (EDTA)<\/td>EDTA tube (purple cap)<\/td>5 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>30<\/td>\n<\/tr>\n
186<\/td>NPM1 Gene Mutation Analysis<\/td>NPM1 (Exon 12)<\/td>\u2022 Cancer<\/td>Sequence Analysis<\/td>Blood (EDTA), Bone Marrow (EDTA)<\/td>EDTA tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
187<\/td>NRAS Gene Mutation Analysis<\/td>NRAS (Codons 12, 13, 59, 61, 117, 146)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>Real-Time PCR<\/td>Blood (Streck), FFPE<\/td>EDTA tube (purple cap)<\/td>10 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
188<\/td>NTRK1 Gene Mutation Analysis<\/td>NTRK1 (Whole Gene)<\/td>Cancer<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10<\/td>\n<\/tr>\n
189<\/td>NTRK2 Gene Mutation Analysis<\/td>NTRK2 (Whole Gene)<\/td>Cancer<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10<\/td>\n<\/tr>\n
190<\/td>NTRK3 Gene Mutation Analysis<\/td>NTRK3 (Whole Gene)<\/td>Cancer<\/td>FISH Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10<\/td>\n<\/tr>\n
191<\/td>Osteoporosis Panel<\/td>VDR, CALCR, COL1A1, ESR1<\/td>Recommended for Osteoporosis Diagnosis<\/td>Sequence Analysis<\/td>Blood<\/td>EDTA tube (purple cap)<\/td>2-3 ml<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
192<\/td>OSTM1 Gene Mutation Analysis<\/td>OSTM1 (Whole Gene)<\/td>\u2022 Osteopetrosis<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
193<\/td>Autoinflammatory Diseases Panel<\/td>5-15 Genes<\/td>Autoinflammatory Diseases<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA tube (purple cap)<\/td>5 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>60<\/td>\n<\/tr>\n
194<\/td>p16 Gene Mutation Analysis<\/td>p16 (Whole Gene)<\/td>\u2022 Cancer<\/td>Sequence Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>15<\/td>\n<\/tr>\n
195<\/td>P53 Gene Mutation Analysis<\/td>P53 (Exons 4, 5, 6, 7, 8, 9)<\/td>\u2022 Li-Fraumeni Syndrome Type I, \u2022 Cancer<\/td>Sequence Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>15<\/td>\n<\/tr>\n
196<\/td>PAH Gene Mutation Analysis<\/td>PAH Gene<\/td>Phenylketonuria<\/td>Sequence Analysis<\/td>EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>21<\/td>\n<\/tr>\n
197<\/td>PAI-1 Gene Mutation Analysis<\/td>PAI-1 (4G\/5G)<\/td>\u2022 Cardiovascular Risk<\/td>Real-Time PCR<\/td>EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
198<\/td>PDGFRA Gene Mutation Analysis<\/td>PDGFRA (12, 18, 19)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>Sequence Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>15<\/td>\n<\/tr>\n
199<\/td>PDGFRB Gene Mutation Analysis<\/td>PDGFRB (Exon 18, 19)<\/td>\u2022 Cancer, \u2022 Kosaki Syndrome, \u2022 Infantile Myofibromatosis<\/td>Sequence Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10<\/td>\n<\/tr>\n
200<\/td>PGT-M: Rare Single Gene Diseases<\/td>Targeted Gene Analysis<\/td><\/td>Sequence Analysis<\/td>Day 5 TE Biopsy, Family: Blood (EDTA)<\/td>Special PBS tubes prepared by our center<\/td>5-10 cells<\/td>Room temperature<\/td>8 Weeks<\/td>\n<\/tr>\n
201<\/td>PGT-M: Common Single Gene Diseases<\/td>Thalassemia, CF, SMA, FMF, HLA Typing<\/td>\u2022 Single Gene Disease<\/td>Sequence Analysis<\/td>Day 5 TE Biopsy, Family: Blood (EDTA)<\/td>Special PBS tubes prepared by our center<\/td>5-10 cells<\/td>Room temperature<\/td>6 Weeks<\/td>\n<\/tr>\n
202<\/td>PIK3CA Gene Mutation Analysis<\/td>PIK3CA (Exon 9, 20)<\/td>\u2022 Cancer<\/td>Sequence Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10<\/td>\n<\/tr>\n
203<\/td>PKU Gene Mutation Analysis<\/td>PKU (Whole Gene)<\/td>\u2022 Phenylketonuria Disease<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
204<\/td>PMP22 Gene Duplication Analysis<\/td>PMP22<\/td>\u2022 Charcot-Marie-Tooth (CMT1A)<\/td>Fragment Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
205<\/td>PMP22 Gene Mutation Analysis<\/td>PMP22 (Whole Gene)<\/td>\u2022 Charcot-Marie-Tooth 1A (CMT1A)<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
206<\/td>POLE Gene Mutation Analysis<\/td>POLE (Whole Gene)<\/td>Cancer<\/td>Sequence Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>10<\/td>\n<\/tr>\n
207<\/td>PTEN Gene Mutation Analysis<\/td>PTEN (Whole Gene)<\/td>\u2022 Cancer, \u2022 Drug Treatment Response<\/td>Sequence Analysis<\/td>FFPE<\/td>Paraffin block \/ slides<\/td>5-10 Pcs (4-5 micron thick)<\/td>Shipped at room temperature<\/td>21<\/td>\n<\/tr>\n
208<\/td>PTPN11 Gene Sequence Analysis<\/td>PTPN11<\/td>Noonan Syndrome<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>30<\/td>\n<\/tr>\n
209<\/td>RAB27A Gene Mutation Analysis<\/td>RAB27A (Whole Gene)<\/td>\u2022 Griscelli Syndrome Type 2<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
210<\/td>RAPSN Gene Mutation Analysis<\/td>RAPSN (Whole Gene)<\/td>\u2022 Pena-Shokeir Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
211<\/td>Rasopathy Panel<\/td>A2ML1, ACTB, ACTG1, BRAF, CBL, CCNK, CDC42, EPHB4, FGD1, HRAS, KAT6B, KRAS, LZTR1, MAP2K1, MAP2K2, MAP3K8, MRAS, NF1, NRAS, NSUN2, PPP1CB, PTPN11, RAF1, RASA1, RASA2, RIT1, RRAS, RRAS2, RREB1, SASH1, SHOC2, SOS1, SOS2, SPRED1, YWHAZ<\/td>Noonan, Costello, CFC Syndrome<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>60<\/td>\n<\/tr>\n
212<\/td>RET GENE MUTATION ANALYSIS<\/td>RET (Exons 10, 11, 13, 14, 15, 16)<\/td>\u2022 Cancer \u2022 Multiple Endocrine Neoplasia Type 2A\/2B (MEN2A\/MEN2B)<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>15<\/td>\n<\/tr>\n
213<\/td>RPS19 GENE MUTATION ANALYSIS<\/td>RPS19 (Whole Gene)<\/td>\u2022 Blackfan-Diamond Anemia<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
214<\/td>SBDS GENE MUTATION ANALYSIS<\/td>SBDS (Whole Gene)<\/td>\u2022 Shwachman-Diamond Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
215<\/td>SH2D1A GENE MUTATION ANALYSIS<\/td>SH2D1A (Whole Gene)<\/td>\u2022 Lymphoproliferative Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
216<\/td>SIGNATERA<\/td>16 patient-specific mutations tracked<\/td>All Solid Tumors<\/td>NGS\/Hybrid Capture<\/td>FFPE\/Blood<\/td>EDTA tube (purple cap)<\/td>2-3 mL<\/td>Should be delivered within 24 hours at 15-25 \u00b0C.<\/td>Kurulum (Setup): 6-8 hafta Takip (Follow-up):2-3 hafta<\/td>\n<\/tr>\n
217<\/td>SLC37A4 GENE MUTATION ANALYSIS<\/td>SLC37A4 (Whole Gene)<\/td>\u2022 GSD Type 1B\/1C<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
218<\/td>SMA CARRIER SCREENING<\/td>SMN1-2<\/td>\u2022 Spinal Muscular Atrophy (SMA) Carrier Screening<\/td>Real-Time PCR<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>7<\/td>\n<\/tr>\n
219<\/td>SMN1-2 GENE MUTATION ANALYSIS (DELETION & DUPLICATION)<\/td>SMN1-2<\/td>\u2022 Spinal Muscular Atrophy (SMA)<\/td>MLPA<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>14<\/td>\n<\/tr>\n
220<\/td>SMPD GENE MUTATION ANALYSIS<\/td>SMPD (Whole Gene)<\/td>\u2022 Niemann-Pick Syndrome<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
221<\/td>SOD1 GENE MUTATION ANALYSIS<\/td>SOD1 (Whole Gene)<\/td>\u2022 Amyotrophic Lateral Sclerosis (ALS)<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
222<\/td>SPERM DNA FRAGMENTATION ANALYSIS<\/td>DNA strand breaks<\/td>Infertility<\/td>TUNEL Assay<\/td>Concentrated Sperm<\/td>Sterile Sperm Container<\/td>2-3ML<\/td>Room temperature. Specify sample status (fresh or fixative) in the form.<\/td>15<\/td>\n<\/tr>\n
223<\/td>SPERM FISH<\/td>Chromosomes 13, 18, 21, X and Y<\/td>\u2022 Infertility<\/td>FISH Analysis<\/td>Concentrated Sperm<\/td>Sterile Sperm Container<\/td>2-3 ML<\/td>Room temperature. Specify sample status (fresh or fixative) in the form.<\/td>3-5<\/td>\n<\/tr>\n
224<\/td>SRD5A2 GENE MUTATION ANALYSIS<\/td>SRD5A2 (Whole Gene)<\/td>\u2022 5\u03b1-Reductase Deficiency Type 2<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
225<\/td>TCIRG GENE MUTATION ANALYSIS<\/td>TCIRG (Whole Gene)<\/td>\u2022 Osteopetrosis<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>30<\/td>\n<\/tr>\n
226<\/td>TOR1A1 GENE GAG DELETION ANALYSIS<\/td>TOR1A1<\/td>\u2022 Dystonia (DYT1)<\/td>Sequence Analysis<\/td>EDTA Blood\/AF\/CVS<\/td>EDTA tube (purple cap)<\/td>2-3ML\/5-20ML\/2-3MG<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>21<\/td>\n<\/tr>\n
227<\/td>TPMT MUTATION ANALYSIS (TPMT*2, *3A, *3B, *3C)<\/td>TPMT (c.238, c.460, c.719)<\/td>\u2022 Azathioprine, 6-Mercaptopurine, 6-Thioguanine Toxicity<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
228<\/td>THROMBOPHILIA PANEL<\/td>Factor II, Factor V, MTHFR C677T, MTHFR A1298C<\/td>\u2022 Cardiovascular Risk<\/td>Real-Time PCR<\/td>EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>7<\/td>\n<\/tr>\n
229<\/td>TSC1-TSC2 Gene Sequence Analysis<\/td>TSC1-TSC2<\/td>Tuberous Sclerosis<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA tube (purple cap)<\/td>2 - 3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>30<\/td>\n<\/tr>\n
230<\/td>WHOLE EXOME SEQUENCING (WES)<\/td>Whole Exome<\/td>Analysis of ~22,000 genes (exons\/junctions) and CNVs.<\/td>NGS<\/td>EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>60<\/td>\n<\/tr>\n
231<\/td>Prenatal WES Analysis (Index)<\/td>Whole Exome<\/td>Exon\/junction analysis of ~22,000 genes. Includes Maternal Contamination test.<\/td>NGS<\/td>AF\/CVS \/ EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3ML<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>60<\/td>\n<\/tr>\n
232<\/td>Whole Genome Sequencing (WGS) Analysis<\/td>Whole Genome<\/td>Analysis of whole genome (exons + introns) and CNV mapping for complex rare diseases.<\/td>NGS<\/td>EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>60<\/td>\n<\/tr>\n
233<\/td>Clinical Exome Sequencing (CES)<\/td>Clinically Related ~5,000 Genes<\/td>Targeted analysis of genes associated with specific clinical phenotypes (e.g. Noonan, Skeletal Dysplasia).<\/td>NGS<\/td>AF\/CVS \/ EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3ML<\/td>Should be delivered within 24 hours at 15-25 \u00b0C. Amniotic and CVS samples must be delivered with ice packs.<\/td>60<\/td>\n<\/tr>\n
234<\/td>UGT1A1 REPEAT ANALYSIS<\/td>UGT1A1*28 (TATA BOX)<\/td>\u2022 Irinotecan Toxicity \u2022 Hereditary Hyperbilirubinemia \u2022 Gilbert Syndrome<\/td>Sequence Analysis<\/td>Blood (EDTA)<\/td>EDTA tube (purple cap)<\/td>2-3 ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n
235<\/td>Y CHROMOSOME MICRODELETION<\/td>Y Chromosome (24 STRs)<\/td>\u2022 Infertility<\/td>Fragment Analysis<\/td>EDTA Blood<\/td>EDTA tube (purple cap)<\/td>2-3ML<\/td>Deliver within 24 hours at 15-25 \u00b0C. Do not place in direct contact with ice due to hemolysis risk.<\/td>10<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Tests marked with (*) are accredited by T\u00dcRKAK.<\/p>

\u2013 Content on this page was revised on 23.02.2026.<\/p>

\u2013 To perform PGT for single-gene disorders, the clinical diagnosis of the disease must be established within the family, and the mutation must be identified through genetic testing.<\/p>

\u2013 If the mutation has not been identified, additional time is required to identify it by analyzing the gene responsible for the disease (at a local or international center).<\/p>

\u2013 If the mutation has been identified, a set-up procedure is mandatory prior to IVF and PGT for mutations falling into our “other disease group.”<\/p>

\u2013 Our tests are open for sample acceptance and processing on weekdays from 09:00 to 18:00 and on Saturdays from 09:00 to 14:00.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

\u00d6zel Nesiller Genetik Test List Tests marked with (*) are accredited by […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-12919","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/12919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/comments?post=12919"}],"version-history":[{"count":18,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/12919\/revisions"}],"predecessor-version":[{"id":20744,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/12919\/revisions\/20744"}],"wp:attachment":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/media?parent=12919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}